We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

ACTIV-2: A Study for Outpatients With COVID-19

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04518410
Recruitment Status : Active, not recruiting
First Posted : August 19, 2020
Last Update Posted : March 9, 2023
Eli Lilly and Company
AIDS Clinical Trials Group
Brii Biosciences Limited
Sagent Pharmaceuticals
Synairgen Research Ltd.
Bristol-Myers Squibb
SAb Biotherapeutics, Inc.
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : April 7, 2022
Estimated Study Completion Date : June 22, 2023
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):